Peer Group

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Drug Manufacturers—Specialty & Generic Average - - - - - - 586,448.79 34,310.31 1,620.91 122,571.36 -833.00 0.13 24.2548 41.57 25.7603 -148.0397 0.06 4.25 195.7628 - -
Maximum - - - - - - 9,150,452.00 444,593.00 12,710.00 1,955,691.00 6,978.00 0.86 268.1192 319.88 78.4900 69.5400 7.56 145.73 1,374.4000 - -
Minimum - - - - - - 0.00 0.00 -99.00 -13,707.00 -17,092.00 0.00 -183.3601 -0.63 -392.5400 -4,237.3100 -30.79 -89.90 0.0000 - -
Neurocrine Biosciences, Inc. NBIX 119.85 -2.46 -2.01% 1,040 vs. 923 12,101.00 515.00 43.00 119.00 -113.00 0.4300 81.2772 0.00 97.52 8.42 1.82 1.25 233.03 100.00
Intra-Cellular Therapies, Inc. ITCI 74.70 -0.41 -0.55% 429 vs. 952 7,893.00 144.00 -15.00 -34.00 -1,632.00 -0.1600 -108.4422 0.00 93.17 -10.52 -2.54 -2.04 451.43 105.00
Haleon plc HLN 10.55 -0.10 -0.94% 6,295 vs. 3,849 48,103.00 2,919.00 423.00 0.00 0.00 4.6000 18.0545 0.00 62.97 14.49 2.53 0.00 0.00 4,559.00
Catalent, Inc. CTLT 60.32 -0.03 -0.05% 2,431 vs. 1,847 10,945.00 1,074.00 -101.00 -62.00 -804.00 -0.5500 -25.4034 0.00 21.32 -9.40 -2.80 -1.02 155.71 181.00
Viatris Inc. VTRS 11.90 0.08 0.68% 6,217 vs. 8,346 14,202.00 3,656.00 113.00 563.00 4,607.00 0.0953 31.3228 1.00 41.57 3.11 0.57 0.24 65.07 1,193.00
Amphastar Pharmaceuticals, Inc. AMPH 49.78 1.14 2.34% 520 vs. 389 2,423.00 171.00 43.00 46.00 452.00 0.9000 12.1264 0.00 50.80 25.13 6.42 2.74 168.56 48.00
Zoetis Inc. ZTS 196.48 0.77 0.39% 1,681 vs. 2,015 89,015.00 2,190.00 599.00 455.00 10,696.00 1.3100 31.9262 0.26 68.95 27.35 11.84 4.17 171.19 453.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for ZTS and its peers to uncover potential buy and sell opportunities.